Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Strasser

Showing results (51-60 of 320) with videos related to

Pageof 32
Sort By:
International Immunology|May 17, 2003
Autoimmune kidney disease and lymphadenopathy in NODlpr mice are not modified by deficiency in tumor necrosis factor receptor 1 or beta 2-microglobulinTara Catterall, Dina Stockwell, Vikki Marshall, et al.
Nature Reviews. Cancer|April 4, 2009
Unleashing the power of inhibitors of oncogenic kinases through BH3 mimeticsMark S Cragg, Claire Harris, Andreas Strasser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2011
Bid and Bim collaborate during induction of T cell death in persistent infectionFrederick Masson, Fiona Kupresanin, Adele Mount, et al.
Nature Cell Biology|April 13, 2004
Egalitarian binds dynein light chain to establish oocyte polarity and maintain oocyte fateCaryn Navarro, Hamsa Puthalakath, Jerry M Adams, et al.
Blood|April 8, 2015
Antagonism between MCL-1 and PUMA governs stem/progenitor cell survival during hematopoietic recovery from stressAlex R D Delbridge, Joseph T Opferman, Stephanie Grabow, et al.
Cell Death and Differentiation|April 7, 2022
What can we learn from mice lacking pro-survival BCL-2 proteins to advance BH3 mimetic drugs for cancer therapy?Kerstin Brinkmann, Ashley P Ng, Carolyn A de Graaf, et al.
The New England Journal of Medicine|October 16, 2009
Cell deathRichard S Hotchkiss, Andreas Strasser, Jonathan E McDunn, et al.
Cell Death & Disease|April 8, 2022
Some mice lacking intrinsic, as well as death receptor induced apoptosis and necroptosis, can survive to adulthoodFrancine F S Ke, Kerstin Brinkmann, Anne K Voss, et al.
Nature Reviews. Cancer|January 30, 2016
Thirty years of BCL-2: translating cell death discoveries into novel cancer therapiesAlex R D Delbridge, Stephanie Grabow, Andreas Strasser, et al.
Blood|November 5, 2014
MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient miceStephanie Grabow, Alex R D Delbridge, Liz J Valente, et al.
Pageof 32

Showing results (51-60 of 320) with videos related to

Sort By:
Pageof 32
International Immunology|May 17, 2003
Autoimmune kidney disease and lymphadenopathy in NODlpr mice are not modified by deficiency in tumor necrosis factor receptor 1 or beta 2-microglobulinTara Catterall, Dina Stockwell, Vikki Marshall, et al.
Nature Reviews. Cancer|April 4, 2009
Unleashing the power of inhibitors of oncogenic kinases through BH3 mimeticsMark S Cragg, Claire Harris, Andreas Strasser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2011
Bid and Bim collaborate during induction of T cell death in persistent infectionFrederick Masson, Fiona Kupresanin, Adele Mount, et al.
Nature Cell Biology|April 13, 2004
Egalitarian binds dynein light chain to establish oocyte polarity and maintain oocyte fateCaryn Navarro, Hamsa Puthalakath, Jerry M Adams, et al.
Blood|April 8, 2015
Antagonism between MCL-1 and PUMA governs stem/progenitor cell survival during hematopoietic recovery from stressAlex R D Delbridge, Joseph T Opferman, Stephanie Grabow, et al.
Cell Death and Differentiation|April 7, 2022
What can we learn from mice lacking pro-survival BCL-2 proteins to advance BH3 mimetic drugs for cancer therapy?Kerstin Brinkmann, Ashley P Ng, Carolyn A de Graaf, et al.
The New England Journal of Medicine|October 16, 2009
Cell deathRichard S Hotchkiss, Andreas Strasser, Jonathan E McDunn, et al.
Cell Death & Disease|April 8, 2022
Some mice lacking intrinsic, as well as death receptor induced apoptosis and necroptosis, can survive to adulthoodFrancine F S Ke, Kerstin Brinkmann, Anne K Voss, et al.
Nature Reviews. Cancer|January 30, 2016
Thirty years of BCL-2: translating cell death discoveries into novel cancer therapiesAlex R D Delbridge, Stephanie Grabow, Andreas Strasser, et al.
Blood|November 5, 2014
MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient miceStephanie Grabow, Alex R D Delbridge, Liz J Valente, et al.
Pageof 32